Hanall Biopharma Revenue

Hanall Biopharma had revenue of 36.15B KRW in the quarter ending March 31, 2025, with 6.03% growth. This brings the company's revenue in the last twelve months to 141.00B, up 0.57% year-over-year. In the year 2024, Hanall Biopharma had annual revenue of 138.94B with 2.99% growth.

Revenue (ttm)

141.00B

Revenue Growth

+0.57%

P/S Ratio

9.23

Revenue / Employee

463.82M

Employees

304

Market Cap

1,301.48B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	138.94B	4.03B	2.99%
Dec 31, 2023	134.91B	24.91B	22.65%
Dec 31, 2022	110.00B	8.40B	8.27%
Dec 31, 2021	101.59B	12.99B	14.66%
Dec 31, 2020	88.60B	-19.85B	-18.30%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	4,898.69B
Celltrion	3,662.23B
ALTEOGEN	151.65B
Yuhan	2,114.76B
SK Biopharmaceuticals	578.00B
HLB Co., Ltd.	74.64B
PharmaResearch	392.31B
Peptron	4.30B

Revenue Rankings